drugset / Trial / NCT00069082

Intranasal Civamide for Episodic Cluster Headache

NCT00069082 ↗

Phase 3 Completed 2 enrolled Winston Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

Timeline

Start
2003-08
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zucapsaicin Small molecule 0.01 % Intranasal